Sarcoidosis: a pediatric perspective

Area of Science:

• Pediatrics
• Rheumatology
• Pulmonology

Background:

• Childhood sarcoidosis is a rare multisystemic granulomatous disease with unknown etiology.
• Clinical presentation varies based on organ involvement, with two distinct forms in children.
• Older children often exhibit multisystem disease similar to adults, featuring hilar lymphadenopathy and pulmonary infiltration.

Purpose of the Study:

• To describe the distinct clinical presentations and management of childhood sarcoidosis.

Main Methods:

• Diagnosis is confirmed by biopsy showing noncaseating granulomas.
• Treatment for multisystem involvement typically involves corticosteroids.
• Low-dose oral methotrexate is evaluated for efficacy and safety.

Main Results:

• Early-onset childhood sarcoidosis presents with a triad of rash, uveitis, and arthritis in children under 4.
• Corticosteroids are the primary treatment for multisystemic disease.
• Methotrexate demonstrates effectiveness, safety, and steroid-sparing properties.

Conclusions:

• Childhood sarcoidosis requires tailored management based on presentation.
• Corticosteroids remain a cornerstone of treatment for multisystemic forms.
• Methotrexate is a viable steroid-sparing option in pediatric sarcoidosis management.